Abstract:Summary Background COVID-19 pandemic has developed rapidly and the ability to stratify the most vulnerable patients is vital. However, routinely used severity scoring systems are often low on diagnosis, even in non-survivors. Therefore, clinical prediction models for mortality are urgently required. Methods We developed and internally validated a multivariable logistic regression model to predict inpatient mortality in COVID-19 positive patients using data collected retrospectively from Tongji Hospital, Wuhan (299 patients). External validation was conducted using a retrospective cohort from Jinyintan Hospital, Wuhan (145 patients). Nine variables commonly measured in these acute settings were considered for model development, including age, biomarkers and comorbidities. Backwards stepwise selection and bootstrap resampling were used for model development and internal validation. We assessed discrimination via the C statistic, and calibration using calibration-in-the-large, calibration slopes and plots. Findings The final model included age, lymphocyte count, lactate dehydrogenase and SpO 2 as independent predictors of mortality. Discrimination of the model was excellent in both internal (c=0·89) and external (c=0·98) validation. Internal calibration was excellent (calibration slope=1). External validation showed some over-prediction of risk in low-risk individuals and under-prediction of risk in high-risk individuals prior to recalibration. Recalibration of the intercept and slope led to excellent performance of the model in independent data. Interpretation COVID-19 is a new disease and behaves differently from common critical illnesses. This study provides a new prediction model to identify patients with lethal COVID-19. Its practical reliance on commonly available parameters should improve usage of limited healthcare resources and patient survival rate. Funding This study was supported by following funding: Key Research and Development Plan of Jiangsu Province (BE2018743 and BE2019749), National Institute for Health Research (NIHR) (PDF-2018-11-ST2-006), British Heart Foundation (BHF) (PG/16/65/32313) and Liverpool University Hospitals NHS Foundation Trust in UK. Research in context Evidence before this study Since the outbreak of COVID-19, there has been a pressing need for development of a prognostic tool that is easy for clinicians to use. Recently, a Lancet publication showed that in a cohort of 191 patients with COVID-19, age, SOFA score and D-dimer measurements were associated with mortality. No other publication involving prognostic factors or models has been identified to date. Added value of this study In our cohorts of 444 patients from two hospitals, SOFA scores were low in the majority of patients on admission. The relevance of D-dimer could not be verified, as it is not included in routine laboratory tests. In this study, we have established a multivariable clinical prediction model using a development cohort of 299 patients from one hospital. After backwards selection, four variables, including age, lymphocyte count, lactate dehydrogenase and SpO 2 remained in the model to predict mortality. This has been validated internally and externally with a cohort of 145 patients from a different hospital. Discrimination of the model was excellent in both internal (c=0·89) and external (c=0·98) validation. Calibration plots showed excellent agreement between predicted and observed probabilities of mortality after recalibration of the model to account for underlying differences in the risk profile of the datasets. This demonstrated that the model is able to make reliable predictions in patients from different hospitals. In addition, these variables agree with pathological mechanisms and the model is easy to use in all types of clinical settings. Implication of all the available evidence After further external validation in different countries the model will enable better risk stratification and more targeted management of patients with COVID-19. With the nomogram, this model that is based on readily available parameters can help clinicians to stratify COVID-19 patients on diagnosis to use limited healthcare resources effectively and improve patient outcome.

Derivation and Validation of a Prediction Rule for Mortality of Patients with Respiratory Virus-Related Pneumonia (Rv-P Score).

Clinical Features Predicting Mortality Risk in Patients with Viral Pneumonia: the MuLBSTA Score

FluA-p Score: a Novel Prediction Rule for Mortality in Influenza A-related Pneumonia Patients

Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome

Development and Validation of a Scoring System to Predict the Mortality of Hospitalized Patients with SARS-CoV-2 Omicron: a Nationwide, Multicentre Study

A Model to Predict In-hospital Mortality in Elderly Patients with Community-acquired Pneumonia: a Retrospective Study

Performance and Comparison of Assessment Models to Predict 30-Day Mortality in Patients with Hospital-Acquired Pneumonia

CAPRL Scoring System for Prediction of 30-Day Mortality in 949 Patients with Coronavirus Disease 2019 in Wuhan, China: A Retrospective, Observational Study

A Prediction Model for In-Hospital Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Patients Based on Red Cell Distribution Width-to-Platelet Ratio

Mortality prediction for patients with acute respiratory distress syndrome based on machine learning: a population-based study

The risk factors and predictive modeling of mortality in patients with mental disorders combined with severe pneumonia

Prediction Model for Death in Patients with Pulmonary Tuberculosis Accompanied by Respiratory Failure in ICU: Retrospective Study

A model to predict the risk of mortality in severely ill COVID-19 patients

Development and Validation of Risk Prediction Model for In-hospital Mortality Among Patients Hospitalized With Acute Exacerbation Chronic Obstructive Pulmonary Disease Between 2015 and 2019

Development and validation of a predictive model for 30-day mortality in patients with severe community-acquired pneumonia in intensive care units

Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia

Interpretable mortality prediction model for ICU patients with pneumonia: using shapley additive explanation method

Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China

Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19

Risk factors analysis and prediction model construction for severe pneumonia in older adult patients